Dalbavancin for treating prosthetic joint infections caused by Gram-positive bacteria: A proposal for a low dose strategy. A retrospective cohort study

BACKGROUND: Gram-positive bacteria are the leading cause of prosthetic joint infection (PJI). Dalbavancin is a lipoglycopeptide with remarkable pharmacokinetic properties and high bactericidal activity against most Gram-positive bacteria. Although clear evidence regarding its effectiveness in bone a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Rev Esp Quimioter
Huvudupphovsmän: Martín, Luis Buzón, Fernández, María Mora, Perales Ruiz, Jose Manuel, Lafont, Maria Ortega, Paredes, Ledicia Álvarez, Morán Rodríguez, Miguel Ángel, Regueras, María Fernández, Machín Morón, Maria Ángeles, Lobón, Gregoria Mejías
Materialtyp: Artigo
Språk:Inglês
Publicerad: Sociedad Española de Quimioterapia 2019
Ämnen:
Original
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913079/
https://ncbi.nlm.nih.gov/pubmed/31642637
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk